Syros Pharmaceuticals Stock Price Prediction
| SYRS Stock | USD 5.11 0.45 8.09% |
Oversold Vs Overbought
29
Oversold | Overbought |
Syros Pharmaceuticals stock price prediction is an act of determining the future value of Syros Pharmaceuticals shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Syros Pharmaceuticals' future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Syros Pharmaceuticals and does not consider all of the tangible or intangible factors available from Syros Pharmaceuticals' fundamental data. We analyze noise-free headlines and recent hype associated with Syros Pharmaceuticals, which may create opportunities for some arbitrage if properly timed.
Below are the key fundamental drivers impacting Syros Pharmaceuticals' stock price prediction:EPS Estimate Next Quarter (0.95) | EPS Estimate Current Year (3.69) | EPS Estimate Next Year (3.34) | Wall Street Target Price 19.25 | EPS Estimate Current Quarter (1.14) |
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Syros Pharmaceuticals based on different types of headlines from major news networks to social media. The Syros stock price prediction module provides an analysis of price elasticity to changes in media outlook on Syros Pharmaceuticals over a specific investment horizon. Using Syros Pharmaceuticals hype-based prediction, you can estimate the value of Syros Pharmaceuticals from the perspective of Syros Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Syros Pharmaceuticals using Syros Pharmaceuticals' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Syros using crowd psychology based on the activity and movement of Syros Pharmaceuticals' stock price.
Syros Pharmaceuticals Implied Volatility | 0.0 |
Syros Pharmaceuticals' implied volatility exposes the market's sentiment of Syros Pharmaceuticals stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Syros Pharmaceuticals' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Syros Pharmaceuticals stock will not fluctuate a lot when Syros Pharmaceuticals' options are near their expiration.
This module is based on analyzing investor sentiment around taking a position in Syros Pharmaceuticals. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Syros Pharmaceuticals to buy its stock at a price that has no basis in reality. In that case, they are not buying Syros because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Syros Pharmaceuticals after-hype prediction price | USD 5.5 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Syros |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Syros Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Syros Pharmaceuticals After-Hype Price Prediction Density Analysis
As far as predicting the price of Syros Pharmaceuticals at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Syros Pharmaceuticals or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Syros Pharmaceuticals, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Syros Pharmaceuticals Estimiated After-Hype Price Volatility
In the context of predicting Syros Pharmaceuticals' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Syros Pharmaceuticals' historical news coverage. Syros Pharmaceuticals' after-hype downside and upside margins for the prediction period are 0.52 and 10.48, respectively. We have considered Syros Pharmaceuticals' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Syros Pharmaceuticals is slightly risky at this time. Analysis and calculation of next after-hype price of Syros Pharmaceuticals is based on 3 months time horizon.
Syros Pharmaceuticals Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Syros Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Syros Pharmaceuticals backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Syros Pharmaceuticals, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.29 | 5.08 | 0.11 | 0.10 | 9 Events / Month | 15 Events / Month | In about 9 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
5.11 | 5.50 | 1.08 |
|
Syros Pharmaceuticals Hype Timeline
Syros Pharmaceuticals is at this time traded for 5.11. The entity has historical hype elasticity of -0.11, and average elasticity to hype of competition of -0.1. Syros is projected to decline in value after the next headline, with the price expected to drop to 5.5. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -1.08%, whereas the daily expected return is at this time at -0.29%. The volatility of related hype on Syros Pharmaceuticals is about 1430.99%, with the expected price after the next announcement by competition of 5.01. About 81.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 5.81. Syros Pharmaceuticals had not issued any dividends in recent years. The entity had 1:10 split on the 19th of September 2022. Given the investment horizon of 90 days the next projected press release will be in about 9 days. Check out Syros Pharmaceuticals Basic Forecasting Models to cross-verify your projections.Syros Pharmaceuticals Related Hype Analysis
Having access to credible news sources related to Syros Pharmaceuticals' direct competition is more important than ever and may enhance your ability to predict Syros Pharmaceuticals' future price movements. Getting to know how Syros Pharmaceuticals' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Syros Pharmaceuticals may potentially react to the hype associated with one of its peers.
Syros Pharmaceuticals Additional Predictive Modules
Most predictive techniques to examine Syros price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Syros using various technical indicators. When you analyze Syros charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Syros Pharmaceuticals Predictive Indicators
The successful prediction of Syros Pharmaceuticals stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Syros Pharmaceuticals, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Syros Pharmaceuticals based on analysis of Syros Pharmaceuticals hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Syros Pharmaceuticals's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Syros Pharmaceuticals's related companies. | 2021 | 2023 | 2024 (projected) | Dividend Yield | 0.19 | 0.17 | 0.18 | Price To Sales Ratio | 8.68 | 22.21 | 21.1 |
Story Coverage note for Syros Pharmaceuticals
The number of cover stories for Syros Pharmaceuticals depends on current market conditions and Syros Pharmaceuticals' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Syros Pharmaceuticals is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Syros Pharmaceuticals' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
View All Premium Stories
Syros Pharmaceuticals Short Properties
Syros Pharmaceuticals' future price predictability will typically decrease when Syros Pharmaceuticals' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Syros Pharmaceuticals often depends not only on the future outlook of the potential Syros Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Syros Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 28.3 M | |
| Cash And Short Term Investments | 139.5 M |
Check out Syros Pharmaceuticals Basic Forecasting Models to cross-verify your projections. For more information on how to buy Syros Stock please use our How to Invest in Syros Pharmaceuticals guide.You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Complementary Tools for Syros Stock analysis
When running Syros Pharmaceuticals' price analysis, check to measure Syros Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Syros Pharmaceuticals is operating at the current time. Most of Syros Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Syros Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Syros Pharmaceuticals' price. Additionally, you may evaluate how the addition of Syros Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Money Managers Screen money managers from public funds and ETFs managed around the world |
Is Syros Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Syros Pharmaceuticals. If investors know Syros will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Syros Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (5.81) | Revenue Per Share 0.351 | Quarterly Revenue Growth (0.03) | Return On Assets (0.38) | Return On Equity (2.28) |
The market value of Syros Pharmaceuticals is measured differently than its book value, which is the value of Syros that is recorded on the company's balance sheet. Investors also form their own opinion of Syros Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Syros Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Syros Pharmaceuticals' market value can be influenced by many factors that don't directly affect Syros Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Syros Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Syros Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Syros Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.